The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > SciClone Pharmaceuticals, Inc.

SciClone Pharmaceuticals, Inc.
Nasdaq: SCLN
Change
symbol:
     
 PROFILE
Here comes the twister! SciClone Pharmaceuticals makes drugs for treating chronic and life-threatening diseases. The firm's flagship product, ZADAXIN, is approved in some 20 countries to treat hepatitis B and C. It is also used as an influenza vaccine adjuvant in patients with weakened immune systems. SciClone is working to expand the drug's indications for hepatitis B and C, as well as for liver and skin cancer. It is developing CPX as a gene therapy for cystic fibrosis (CF); other drug candidates also target CF and drug-resistant tuberculosis. The firm has an agreement with Schering-Plough to develop and market ZADAXIN in Japan; it has a similar deal with Sigma-Tau covering the European Union.

 COMPETITION
Enzon, Inc. (ENZN)
GlaxoSmithKline plc (GSK)
Schering-Plough Corporation (SGP)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 15.40
1-Yr. Sales Growth: 63.8%
Employees: 71
Revenue per employee: $216,901.41

 KEY PEOPLE
• Donald R. Sellers
    CEO
• Richard A. Waldron
    CFO

 CONTACT INFO
901 Mariner's Island Blvd., Ste. 205
San Mateo, CA 94404
US
Phone: 650-358-3456
Fax: 650-358-3469
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001